S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
How major US stock indexes fared Thursday, 4/11/2024
Closing prices for crude oil, gold and other commodities
Carmax Returns to the Bargain Basement: Buy the Dip? 
Homebuyers’ quandary: to wait or not to wait for lower mortgage rates
S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
How major US stock indexes fared Thursday, 4/11/2024
Closing prices for crude oil, gold and other commodities
Carmax Returns to the Bargain Basement: Buy the Dip? 
Homebuyers’ quandary: to wait or not to wait for lower mortgage rates
S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
How major US stock indexes fared Thursday, 4/11/2024
Closing prices for crude oil, gold and other commodities
Carmax Returns to the Bargain Basement: Buy the Dip? 
Homebuyers’ quandary: to wait or not to wait for lower mortgage rates
S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
How major US stock indexes fared Thursday, 4/11/2024
Closing prices for crude oil, gold and other commodities
Carmax Returns to the Bargain Basement: Buy the Dip? 
Homebuyers’ quandary: to wait or not to wait for lower mortgage rates

Amedisys (AMED) Earnings Date, Estimates & Call Transcripts

$92.27
0.00 (0.00%)
(As of 04/11/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 1Estimated
Actual EPS
(Feb. 21)
$0.94 Missed By -$0.10
Consensus EPS
(Feb. 21)
$1.04
Skip Charts & View Estimated and Actual Earnings Data

AMED Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AMED Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Amedisys Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20245$0.85$1.31$1.04 
Q2 20244$1.04$1.38$1.20 
Q3 20244$0.98$1.28$1.14 
Q4 20245$1.00$1.30$1.18 
FY 202418$3.87$5.27$4.55 
Q1 20251$1.03$1.03$1.03 
Q2 20251$1.28$1.28$1.28 
Q3 20251$1.20$1.20$1.20 
Q4 20251$0.98$0.98$0.98 
FY 20254$4.49$4.49 $4.49

AMED Earnings Date and Information

Amedisys last released its earnings data on February 21st, 2024. The health services provider reported $0.94 earnings per share for the quarter, missing analysts' consensus estimates of $1.04 by $0.10. The firm earned $570.79 million during the quarter, compared to analysts' expectations of $566.85 million. Its revenue for the quarter was up 1.6% on a year-over-year basis. Amedisys has generated ($0.31) earnings per share over the last year (($0.31) diluted earnings per share). Earnings for Amedisys are expected to grow by 9.47% in the coming year, from $4.54 to $4.97 per share. Amedisys has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off prior year's report dates.

Amedisys Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/1/2024
Estimated)
------- 
2/21/2024Q4 2023$1.04$0.94($0.10)$1.29$566.85 million$570.79 million  
10/24/2023Q3 2023$1.08$0.98($0.10)$1.17$560.23 million$556.24 million  
7/26/2023Q2 2023$1.09$1.37+$0.28$5.20$568.18 million$552.97 million  
5/4/2023Q1 2023$0.86$1.00+$0.14$1.23$558.98 million$556.39 million    
2/16/2023Q4 2022$1.03$1.16+$0.13$1.35$560.46 million$562.10 million      
10/26/2022Q3 2022$1.24$1.15($0.09)$1.51$579.30 million$557.99 million      
7/27/2022Q2 2022$1.23$1.47+$0.24$2.03$583.12 million$557.89 million    
4/27/2022Q1 2022$1.11$1.23+$0.12$1.49$557.81 million$545.26 million      
2/23/2022Q4 2021$1.17$1.18+$0.01$1.32$555.18 million$559.32 million    
11/2/2021Q3 2021$1.37$1.53+$0.16$1.69$568.55 million$553.49 million    
8/4/2021Q2 2021$1.67$1.69+$0.02$0.95$565.48 million$564.17 million    
4/27/2021Q1 2021$1.43$1.54+$0.11$1.58$544.89 million$537.10 million    

Amedisys Earnings - Frequently Asked Questions

When is Amedisys's earnings date?

Amedisys has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off last year's report dates. Learn more on AMED's earnings history.

Did Amedisys beat their earnings estimates last quarter?

In the previous quarter, Amedisys (NASDAQ:AMED) missed the analysts' consensus estimate of $1.04 by $0.10 with a reported earnings per share (EPS) of $0.94. Learn more on analysts' earnings estimate vs. AMED's actual earnings.

How can I view Amedisys's earnings report?

Amedisys's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Amedisys generate each year?

Amedisys (NASDAQ:AMED) has a recorded annual revenue of $2.24 billion.

How much profit does Amedisys generate each year?

Amedisys (NASDAQ:AMED) has a recorded net income of -$9.75 million. AMED has generated -$0.31 earnings per share over the last four quarters.

What is Amedisys's price-to-earnings ratio?

Amedisys (NASDAQ:AMED) has a forward price-to-earnings ratio of 20.32. The price/earnings-to-growth ratio is 4.34.

What is Amedisys's EPS forecast for next year?

Amedisys's earnings are expected to grow from $4.54 per share to $4.97 per share in the next year, which is a 9.47% increase.


More Earnings Resources from MarketBeat

This page (NASDAQ:AMED) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners